IL288419A - Recombinant viral herpes vector - Google Patents

Recombinant viral herpes vector

Info

Publication number
IL288419A
IL288419A IL288419A IL28841921A IL288419A IL 288419 A IL288419 A IL 288419A IL 288419 A IL288419 A IL 288419A IL 28841921 A IL28841921 A IL 28841921A IL 288419 A IL288419 A IL 288419A
Authority
IL
Israel
Prior art keywords
herpesvirales
recombinant
vector
recombinant herpesvirales
herpesvirales vector
Prior art date
Application number
IL288419A
Other languages
English (en)
Hebrew (he)
Original Assignee
Solid Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solid Biosciences Inc filed Critical Solid Biosciences Inc
Publication of IL288419A publication Critical patent/IL288419A/en

Links

IL288419A 2019-05-30 2021-11-25 Recombinant viral herpes vector IL288419A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962854637P 2019-05-30 2019-05-30
US201962873094P 2019-07-11 2019-07-11
PCT/US2020/035558 WO2020243706A1 (en) 2019-05-30 2020-06-01 Recombinant herpesvirales vector

Publications (1)

Publication Number Publication Date
IL288419A true IL288419A (en) 2022-01-01

Family

ID=71787155

Family Applications (1)

Application Number Title Priority Date Filing Date
IL288419A IL288419A (en) 2019-05-30 2021-11-25 Recombinant viral herpes vector

Country Status (10)

Country Link
US (1) US20220307052A1 (https=)
EP (1) EP3976806A1 (https=)
JP (1) JP2022534119A (https=)
KR (1) KR20220016150A (https=)
CN (1) CN114207120A (https=)
AU (1) AU2020284255A1 (https=)
CA (1) CA3142194A1 (https=)
IL (1) IL288419A (https=)
SG (1) SG11202113052YA (https=)
WO (1) WO2020243706A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114787179A (zh) * 2019-10-10 2022-07-22 坚固生物科技公司 经修饰的aav衣壳及其用途
EP3950948A1 (en) * 2020-08-07 2022-02-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Platform vector for modular and simplified insertion of transgenes into alphaherpesvirinae
WO2022067038A1 (en) * 2020-09-25 2022-03-31 President And Fellows Of Harvard College Immunotherapeutic virus for the treatment of cancer
US20240191251A1 (en) * 2021-04-05 2024-06-13 Solid Biosciences Inc. Recombinant herpesvirales vector
AU2022373653A1 (en) 2021-10-18 2024-05-02 Regeneron Pharmaceuticals, Inc. Eukaryotic cells comprising adenovirus-associated virus polynucleotides
CN114703327B (zh) * 2022-03-29 2024-11-26 广西壮族自治区兽医研究所 检测鸡传染性喉气管炎病毒的组合物及其应用
CN115927473B (zh) * 2022-07-15 2024-06-18 上海本导基因技术有限公司 一种用于单纯疱疹病毒感染性疾病的基因治疗药物
CN120435565A (zh) * 2022-12-01 2025-08-05 免疫医疗有限责任公司 腺相关病毒生产平台
CN116286924A (zh) * 2023-01-06 2023-06-23 齐鲁动物保健品有限公司 一种猫疱疹病毒ⅰ型感染性克隆质粒及其构建

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9700411D0 (en) * 1997-01-10 1997-02-26 Univ London Eukaryotic gene expression cassette and uses thereof
US20040063094A1 (en) * 1998-05-20 2004-04-01 Biovex Limited Mutant herpes simplex viruses and uses thereof
ATE437944T1 (de) 2000-04-28 2009-08-15 Asklepios Biopharmaceutical In Für das dystrophin-minigen kodierende dna- sequenzen und verfahren zu deren verwendung
ATE400656T1 (de) 2000-10-06 2008-07-15 Univ Michigan Mini-dystrophin nukleinsäure- und peptidsequenzen
GB0208390D0 (en) * 2002-04-11 2002-05-22 Univ London Adeno-associated virus producer system
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
JP5575486B2 (ja) 2007-01-18 2014-08-20 ユニヴァーシティ オブ ミズーリー−コロンビア 筋鞘にｎＮＯＳを回復させる合成ミニ／ミクロジストロフィン遺伝子
EP2960336A1 (en) 2014-06-27 2015-12-30 Genethon Efficient systemic treatment of dystrophic muscle pathologies
IL286316B2 (en) 2015-01-16 2023-03-01 Univ Washington New micro-dystrophins and related method of use
MX2019011046A (es) * 2017-03-17 2019-10-17 Res Inst Nationwide Childrens Hospital Administracion de vectores del virus adenoasociado de microdistrofina especifica del musculo para tratar la distrofia muscular.

Also Published As

Publication number Publication date
AU2020284255A1 (en) 2022-01-06
US20220307052A1 (en) 2022-09-29
WO2020243706A1 (en) 2020-12-03
WO2020243706A8 (en) 2021-03-04
CN114207120A (zh) 2022-03-18
JP2022534119A (ja) 2022-07-27
EP3976806A1 (en) 2022-04-06
CA3142194A1 (en) 2020-12-03
SG11202113052YA (en) 2021-12-30
KR20220016150A (ko) 2022-02-08

Similar Documents

Publication Publication Date Title
IL288419A (en) Recombinant viral herpes vector
IL277666A (en) Virus vector evasion antibody
IL257819A (en) Recombinant vectors comprising 2a peptide
GB201800903D0 (en) Vectors
IL277664A (en) Virus vector evasion antibody
GB2590774B (en) Vector
GB202017649D0 (en) Polypeptide
IL288412A (en) peptides
PL3325631T3 (pl) Rekombinowany wektor wirusa orf
GB202007441D0 (en) Polypeptide
IL272655A (en) Recombinant adeno-associated vectors
IL299811A (en) polypeptide
ZA202108996B (en) Viral vector
GB201913974D0 (en) Vector
GB201810052D0 (en) Polypeptide
GB202019879D0 (en) Polypeptide
GB201918693D0 (en) Peptide
GB201906283D0 (en) Vector
IL290019A (en) Peptides to regulate melanocytes
GB201914984D0 (en) Vector
GB201906982D0 (en) Peptides
GB201912632D0 (en) Peptide
GB202119034D0 (en) Polypeptide
GB201902850D0 (en) Antimicroial peptides
GB202105924D0 (en) Polypeptide